intergrated generics inc said its biopharmaceutics inc subsidiary negotiations with manufacturer and distributor generic equivalents brand name prescription drugs company said successful agreement would allow distribute chlorazepate dipotasssium anti anxiety drug with market potential mln dlrs integrated said licensor has asked for anonymity this time finalization agreement expected within two three weeks company said reuter 